Latest News and Press Releases
Want to stay updated on the latest news?
-
SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced new clinical data will be shared...
-
Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Product Type (Instruments, Reagents & Kits, Software & Services), Test Techniques (Flow Cytometry,...
-
The University of Texas MD Anderson Cancer Center and Myriad Genetics announced a five-year strategic alliance.
-
Dublin, Dec. 27, 2024 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market Size, Share, Forecast, & Trends Analysis By Offering, Technology, Application Sample - Global Forecast to...
-
SALT LAKE CITY, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a series of ongoing research...
-
SALT LAKE CITY and FREMONT, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in genetic testing and precision medicine, and Personalis, Inc. (Nasdaq: PSNL)...
-
SALT LAKE CITY, July 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and...
-
Dublin, May 03, 2024 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing Market by Technology, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
-
Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and Region Analysis - Analysis and Forecast,...
-
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific MRD Testing Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The Asia-Pacific MRD...